Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Lupus Nephritis and CYP2B6[original query] |
---|
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis and rheumatism 2004 Jul 50 (7): 2202-10. Takada Kazuki, Arefayene Million, Desta Zeruesenay, Yarboro Cheryl H, Boumpas Dimitrios T, Balow James E, Flockhart David A, Illei Gabor |
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation. British journal of clinical pharmacology 2010 Dec 70 (6): 844-53. Helsby Nuala A, Hui Chung-Yee, Goldthorpe Michael A, Coller Janet K, Soh May Ching, Gow Peter J, De Zoysa Janak Z, Tingle Malcolm |
Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy. Clinical nephrology 2011 May 75 (5): 5. Winoto J, Song H, Hines C, Nagaraja H, Rovin BH |
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide. PloS one 2016 11 (3): e0151696. Audemard-Verger Alexandra, Martin Silva Nicolas, Verstuyft Céline, Costedoat-Chalumeau Nathalie, Hummel Aurélie, Le Guern Véronique, Sacré Karim, Meyer Olivier, Daugas Eric, Goujard Cécile, Sultan Audrey, Lobbedez Thierry, Galicier Lionel, Pourrat Jacques, Le Hello Claire, Godin Michel, Morello Rémy, Lambert Marc, Hachulla Eric, Vanhille Philippe, Queffeulou Guillaume, Potier Jacky, Dion Jean-Jacques, Bataille Pierre, Chauveau Dominique, Moulis Guillaume, Farge-Bancel Dominique, Duhaut Pierre, Saint-Marcoux Bernadette, Deroux Alban, Manuzak Jennifer, Francès Camille, Aumaitre Olivier, Bezanahary Holy, Becquemont Laurent, Bienvenu Bor |
Genetic polymorphisms effect on cyclophosphamide's tolerability and clinical efficacy in Egyptian patients with lupus nephritis. Pharmacogenetics and genomics 2023 8 . Nermeen N Abuelsoud, Engy M El Khate |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: